Drug Database
Back to search

Poland· PL-100497185

Azalia

A desogestrel product containing desogestrelum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 14 of our 19 countries.

ATC G03AC09

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedAzaliaATCG03AC09REGISTER NO.PL-100497185PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about desogestrelumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Desogestrel is registered in 14 of 19 countries.

Countries holding a registration under ATC G03AC09 (desogestrel), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose
Search desogestrel products by name

Desogestrel · ATC G03AC09

14 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Desogestrelum
Manufacturer
Delfarma Sp. z o.o.
Country
Poland (PL)
ATC code
G03AC09
ATC class
Desogestrel
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991538378
  • gtin
    05909991538385

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

86 interactions on record for desogestrel.

Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check desogestrel against other medicinesHow interaction checks work

Desogestrel · interactions on record

86 records

  • 5 severe
  • 55 moderate
  • 1 minor

Most severe, free to view

  • DabrafenibL01EC02severe
  • DabrafenibL01XE23severe
  • BexaroteneL01XF03severe
  • BexarotenL01XX25severe

25 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Desogestrel in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All desogestrel products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Cerazette, Cycle
  • Belgium · Cerazette, Desirett
  • Czechia · Azalia, Cerazette
  • Germany · Cerazette, Chalant
  • Denmark · Azalia, Ceranor
  • Estonia · Cerazette, Delamonie
  • Spain · Aiacet, Azalia
  • Finland · Azalia, Ceranor
  • France · Antigone, Cerazette
  • United Kingdom (Northern Ireland) · Aizea, Cerazette
  • Greece · Cerazette
  • Hungary · Azalia, Cerazette
  • Ireland · Azalia, Cerazette
  • Iceland · Cerazette, Desirett
  • Italy · Aimi, Azalia
  • Lithuania · Azalia, Desirett
  • Luxembourg · Cerazette, Desirett
  • Latvia · Azalia, Desirett
  • Malta · Azalia, Desogestrel Rowex
  • Netherlands · Cerazette, Delamonie
  • Norway · Azalia, Cerazette
  • Portugal · Azalia, Cerazette
  • Romania · Azalia, Cerazette
  • Sweden · Azalia, Ceranor
  • Slovenia · Cerazette, Cerelle
  • Slovakia · Azalia, Desirett

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d5f7f7f4-94eb-471a-a6b5-eaf70cb1f96d
GET /v1/drugs/d5f7f7f4-94eb-471a-a6b5-eaf70cb1f96d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "75 mcg",
  "packaging": "05909991538378 ¦ Rp ¦ 154409\n28 tabl.\n05909991538385 ¦ Rp ¦ 154410\n84 tabl.",
  "substance": "Desogestrelum 75 mcg",
  "common_name": "Desogestrelum",
  "pl_product_id": "100497185",
  "pozwolenie_nr": "191/24",
  "auth_procedure": "IR",
  "authorisation_validity": "2029-05-09"
}
API referenceMCP serverPlans

See everything about desogestrel.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console